Comprehensive screening of multiple epiphyseal dysplasia mutations in Japanese population
Taichi Itoh1, Shuya Shirahama, Eiji Nakashima
1Center for Molecular Biology and Cytogenetics, SRL Inc., Hino, Japan.
Abstract:
Multiple epiphyseal dysplasia (MED) is among the most genetically heterogeneous skeletal dysplasias. Six genes involved in MED, COMP, MATN3, COL9A1, COL9A2, COL9A3, and DTDST have been identified; however, the presence of additional disease genes has been reported, and the detection rate for mutations in known genes accounts for no more than 50% of patients with MED in Western populations. Here, we screened the six known disease genes in 35 consecutive Japanese MED patients. We analyzed the entire coding region of each gene, along with flanking intron-exon junctions, by direct sequencing. A total of 19 mutations were identified in COMP, MATN3, COL9A2, COL9A3, and DTDST. The detection rate for known mutations was higher in this study than in previous reports, and we identified a substantially different spectrum of mutations. Mutations in MATN3 were more prevalent among these Japanese patients, whereas no DTDST mutations were detected. Most of the mutations were localized within specific regions of each gene: COMP mutations were found in the calmodulin-like repeat domains; MATN3 mutations in the von Willebrand factor type A domain; and type IX collagen gene mutations occurred in the third collagenous domains. Based on the integration of clinical and genetic information, we propose an algorithm for detecting mutations in Japanese MED patients. Our study further supports the existence of additional MED gene(s).
Insights
Genetic analysis of Japanese patients with Multiple Epiphyseal Dysplasia (MED) identified 19 mutations in known genes, revealing a distinct mutation spectrum and higher detection rates. This study aids in diagnosing MED and suggests undiscovered genetic causes.
Area of Science:
- Genetics
- Molecular Biology
- Skeletal Dysplasias
Background:
- Multiple Epiphyseal Dysplasia (MED) is a genetically heterogeneous skeletal disorder.
- Known mutations in six genes (COMP, MATN3, COL9A1, COL9A2, COL9A3, DTDST) explain less than 50% of MED cases in Western populations.
Purpose of the Study:
- To screen six known MED genes in 35 Japanese patients.
- To determine the mutation spectrum and detection rate in a Japanese MED cohort.
- To propose a diagnostic algorithm for Japanese MED patients.
Main Methods:
- Direct sequencing of the coding regions and flanking intron-exon junctions of six known MED genes.
- Analysis of 35 consecutive Japanese MED patients.
Main Results:
- Identified 19 mutations in COMP, MATN3, COL9A2, COL9A3, and DTDST genes.
- Achieved a higher mutation detection rate compared to previous studies.
- Observed a different mutation spectrum, with MATN3 mutations being more prevalent and no DTDST mutations found.
- Localized mutations to specific functional domains within the genes.
Conclusions:
- The study identified a distinct genetic landscape of MED in Japanese patients.
- A higher detection rate of known mutations was achieved, improving diagnostic yield.
- The findings support the existence of additional unidentified genes responsible for MED.
- An algorithm for mutation detection in Japanese MED patients is proposed.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
